Heavy Smokers Face Nearly DOUBLE Risk of Being Hospitalized for COVID-19 or Dying Compared to People Who Have Never Smoked

Heavy Smokers Face Nearly DOUBLE Risk of Being Hospitalized for COVID-19 or Dying Compared to People Who Have Never Smoked

28 Jan, 2021
  • Researchers looked at more than 7,000 coronavirus patients, including more than 6,000 never-smokers and the rest being current or former smokers 
  • Patients who had been smoking at least one pack per day for between 10 and 30 years were nearly 1.5 times more likely to be hospitalized from COVID-19
  • Those consuming one pack per day for more than 30 years were 2.25 times more likely to be hospitalized from the disease
  • Patients smoking for more than 30 years were 1.9 times more likely to die from the virus than those who had never smoked before

 

 

Cigarette smokers face a much higher risk of hospitalization and death from COVID-19 compared to those who have never smoked, a new study suggests.

Researchers found that all smokers had higher odds of poor outcomes due to the virus, but those at the highest risk were heavy smokers, defined as those smoking at least one pack per day for more than 30 years.

These patients had nearly double the risk of death due to COVID-19 and were more than twice as likely to be hospitalized because of the disease. 

The team, from the Cleveland Clinic, says its findings are the most complete evidence to date of a cause-and-effect relationship between smoking and an elevated risk of severe illness and death. 

It comes as health officials in states such as New Jersey and Pennsylvania have prioritized smokers in the lines to received the COVID-19 vaccine. 

Research linking smoking status with severe COVID-19 infection and death has been limited and contradictory.  

Early last year, the U.S. Food and Drug Administration (FDA) said that cigarettes can increase the risk of contracting the disease.

'People who smoke cigarettes may be at increased risk of infection with the virus that causes COVID-19, and may have worse outcomes from COVID-19,' the agency said in a statement.

The FDA has previously warned about 'worse outcomes' for coronavirus among smokers but did not specify what that meant.

In addition, a French study found that only 4.4 percent of 350 coronavirus patients hospitalized were regular smokers and theorized that nicotine could prevent the virus from infecting cells.   

For the new study, published in JAMA Internal Medicine, the team examined data for all patients who tested positive for COVID-19 within the Cleveland Clinic Health system in Ohio and Florida between March 8, 2020 and August 25, 2020.

Of the 7,102 patients, the majority - 84.8 percent or 6,020 - had never smoked before. 

Nearly 13 percent were former smokers and about 2.4 percent were current smokers.

A total of 341 were or had been smoking one pack per day between zero and 10 years, 400 had been doing so for 10 to 30 years, and 341 smoked one pack per day for more than 30 years.  

Results showed that the longer patients had been smoking for, the higher their risks were for hospitalization and death. 

Patients who had been smoking at least one pack per day for between 10 and 30 years were nearly 1.5 times more likely to be hospitalized after being diagnosed with COVID-19 than patients who were never-smokers.

Interestingly, although negligible, the risk of death was slightly higher among patients smoking for less than 10 years, who had a 1.6 times higher odds of dying than people who have never smoked.

Those consuming one pack per day for more than 30 years were 2.25 times more likely to be hospitalized from the disease.

Both also had about 1.5 times higher odds of being admitted to the ICU. 

When it came to risk of death, people smoking for zero to 10 years had a 1.6 times higher odds of death, people smoking for 10 to 30 years had a 1.5 times greater risk of death than never-smokers.

For those smoking at least a pack per day for more than 30 years, patients were 1.9 times likely to die. 

The team said there was no difference in the risk of hospital admission and death between current and former smokers.

'The results of this study suggest that cumulative exposure to cigarette smoke is an independent risk factor for hospital admission and death from COVID-19,' they wrote. 

Reference: https://www.dailymail.co.uk/health/article-9184631/Heavy-smokers-face-nearly-DOUBLE-risk-dying-COVID-19-compared-people-never-smoked.html


stay updated

READ ALSO

13 September, 2025

Nicotine has long been tied to cigarettes and addiction, but new research reveals a more complex picture. Studies suggest it may enhance attention, memory, and even offer therapeutic potential for conditions like Alzheimer’s and Parkinson’s. At the same time, developmental risks and strong addictive properties cannot be ignored. Globally, the nicotine pouch market has surged since 2018, with leading brands such as Zyn, Velo, On!, REBEL (by Tobacco International Inc.), and newer entrants like KRATOS reshaping consumer choices. Institutions like GINN are working to set scientific standards and ensure responsible innovation in this fast-growing sector.

Read more

14 August, 2025

Tobacco International Inc., a leading American multinational, today announced a strategic initiative to integrate artificial intelligence (AI) into its flagship brands, Rebel Nicotine Pouches and the newly launched KRATOS, to drive innovation in the smoke-free nicotine and energy pouch industry. The initiative aims to optimize product development, streamline supply chains, and personalize consumer experiences while maintaining strict compliance with global regulatory standards.

Read more

08 August, 2025

KRATOS™ Launches Tropical 8MG in World-Exclusive Partnership with Europouches & SnussieWorld – The new global nicotine pouch brand KRATOS makes its debut with the Tropical 8MG flavor, launching first through Europouches and SnussieWorld before a full 2026 worldwide rollout.

Read more

You must verify that you are over the age of 21 to enter this site.

We use cookies to improve your experience on our site. By continuing to browse it, you agree to our use of cookies. Learn more.